The global lidocaine ointment market is expected to exhibit a CAGR of 7.7% during the forecast period. Due to the increasing approval of new drug for lidocaine ointment formulation. For instance, in ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their ...

The Alembic Pharma stock rose in early trade today after the firm announced its joint venture Aleor Dermaceuticals received approval from USFDA for Lidocaine Ointment USP, 5%. The ointment is used for ...

Alembic Pharmaceuticals Limited on Tuesday has announced that its wholly owned subsidiary, Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration ...

Share price of Strides Pharma Science gained 3.2 percent in the early trade on Thursday after it received approval for Lidocaine Ointment from the United States Food & Drug Administration (USFDA).

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals LLC has launched a new lidocaine product line, starting with lidocaine 5% in ointment form. The company also expects to launch a transdermal ...

New Delhi, Nov 26 (PTI) Alembic Pharmaceuticals Monday said its joint venture Aleor Dermaceuticals has received approval from the US health regulator for Xylocaine ointment, used for temporary relief ...